MedPath

A randomized trial to evaluate effect of mediatation on Stress and Anxiety due to COVID-19 in healthy adult populatio

Not Applicable
Registration Number
CTRI/2020/08/027035
Lead Sponsor
Dr Divya Jain
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Healthy population

1.Participants who complete the online assessment forms and give consent to participate

2. Age group more than 18 years of age

3. Exposed to news about the Covid crisis and access to media/ conversations amounting to at least 1 hour in 1 week

4. Self-reported anxiety/distress due to COVID

5. Ability to understand written and spoken English to give self-report

6. General physical fitment

7. Access to internet and competence to use the same

8. Willing to follow study protocol and timeline

Exclusion Criteria

1.Subjects with history of or current neurological or psychiatric impairment, or cognitive dysfunction that could compromise data collection.

2. Subjects with severe co-morbidity (e.g. uncontrolled hypertension and uncontrolled diabetes mellitus, myocardial infarction or heart failure within 30 days of recruitment) as per investigatorâ??s

assessment.

3. Those already practicing meditation or any other relaxation practice

4. Negligible or mild anxiety due to COVID-19 determined on basis of anxiety score

5. Those who have been diagnosed with COVID and their family members

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1.Relief of stress assessed by perceived stress scale <br/ ><br>2. Decrease in anxiety as measured by Anxiety ScaleTimepoint: 1 month, the parameters studied will be assessed at 15 days and 1 month post intervention
Secondary Outcome Measures
NameTimeMethod
1. Improved psychological well-being assessed by WHO-5 well-being scale <br/ ><br>2.Improvement in felt impact of COVID as evaluated by investigators development questionnaires.Timepoint: 1 month, the parameters studied will be assessed at 15 days and 1 month post intervention
© Copyright 2025. All Rights Reserved by MedPath